Patient Access Seminar will explore route to life-changing medicines
On 28 May, Scotland will host its first Patient Access Seminar, a landmark event exploring how patients in Scotland gain access to innovative medicines in Scotland.
Taking place at the DoubleTree Hilton hotel, the event will delve into the unique approach, processes and pathways enabling Scottish patients to access vital, innovative medicines at fair prices.
Hosted by AXIS, a firm of reimbursement experts in partnership with the Ethical Medicines Industry Group (EMIG), the event will bring together businesses from the Scottish patient access ecosystem. The seminar is intended to highlight the specific processes that make access to medicines easier, and will create opportunities to develop a deeper understanding of the different perspectives of those involved in supporting access of medicines to patients.
This unique event will provide an open platform to foster meaningful dialogue and identify practical solutions that can enhance healthcare outcomes in Scotland.
'At the heart of this conference is mutual recognition and collaboration,' said Brenda Dooley, Chief Executive at AXIS and Managing Secretariat of EMIG Scotland. 'This event is about finding common ground, focusing on the strides Scotland has taken to maximise access and doing more of that to ensure patients are at the heart of decision making across the stakeholder community.
Exploring Scotland's healthcare landscape
The Patient Access Seminar will spotlight the specific strengths of the Scottish system since the publication of the Montgomery report almost 10 years ago – including the Patient and Clinician Engagement (PACE) process and Ultra-Orphan Medicine Pathway facilitating early access to new orphan drugs.
While recognising the challenges around expediting access to new treatments – Scotland was ranked twelfth for availability to new medicines in the latest EFPIA Patients W.A.I.T Indicator Report – this event will focus on the innovative approaches and schemes Scotland has taken to support equitable access to promising new medicines, heralding the nation as an example for other countries to follow.
Scotland's first Patient Access Seminar will feature two expert-led panel discussions with several keynote speakers, addressing topics such as the role of research and evidence generation, access routes to medicines treating rare diseases, the impact of the PACE approach, and the evolution of the Scottish healthcare system.
Speakers include prominent figures shaping the Scottish healthcare landscape, such as Professor Alison Strath, Chief Pharmaceutical Officer for the Scottish Government, Sir Michael Ferguson, Regius Professor of Life Sciences at the University of Dundee, Dr Jane Haley, MBE, Director of Research, MND Scotland and Henry Simmons, Chief Executive, Alzheimer's Scotland. Crucially, the patient voice, delivered through Patient Groups and individuals themselves, will be given the chance to share their views and experiences.
By sharing expert insights alongside personal accounts, the event aims to capture the human impact of industry processes and help bridge the gap between policy and practice to ensure patients are at the heart of decision-making across all stakeholders.
A catalyst for change
Brenda Dooley emphasised the importance of collaboration, and said: 'Scotland has the potential to lead the way in early patient access. But to do so, we need to focus on what works well in the system and do more of it – patients are counting on us all.'
The seminar aligns with Scotland's commitment to advancing healthcare innovation while recognising the economic realities of healthcare funding. By shining a light on solutions like streamlined reimbursement processes and enhanced communication among stakeholders, it aims to deliver actionable strategies for overcoming existing barriers.
This event is free of charge and will run from 10 am to 4 pm on 28 May at the DoubleTree by Hilton at Edinburgh Airport.
Like this:
Like
Related
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Powys County Times
20 hours ago
- Powys County Times
Chris Hoy calls for systemic change in testing for prostate cancer
Six-time Olympic champion Sir Chris Hoy has called for systemic change in the ways men get tested for prostate cancer. The 49-year old cyclist was diagnosed with stage four prostate cancer in 2023 and was told last year that it has spread to his bones and is terminal. NHS guidance says men over the age of 50 are at highest risk of developing prostate cancer, but Sir Chris wants to help men get screened earlier. He said: 'I was diagnosed with stage four prostate cancer at 47. By this age, my prostate cancer was advanced and could have been progressing from when I was 45 or even younger. 'With prostate cancer, the earlier you find it, the easier it is to treat. We need the system to change to enable more men to get diagnosed earlier, and stop them getting the news I got.' One option is a PSA blood test which checks the level of prostate-specific antigens in the blood, A high reading may be a sign of a prostate condition. NHS guidance says these tests are not routinely used as they are not reliable, but men over 50 can ask GPs for one. Sir Chris's comments came after Prostate Cancer UK urged the UK Government for an overhaul of NHS guidelines to encourage GPs to proactively speak to men at high risk from 45 years old. #ProstateCancer has become the most common cancer in England. However, for a disease that affects 1 in 8 men, there's still no screening programme and outdated NHS guidelines prevent lifesaving conversations with men at highest risk. ➡️ Read more: — Prostate Cancer UK (@ProstateUK) January 28, 2025 According to the charity, around one in eight men in the UK will get prostate cancer, which occurs when cells in the prostate start to grow in an uncontrolled way and, if not detected early, risks spreading. Sir Chris added: 'I believe men at highest risk, for example men with a family history like me or black men, should be contacted by their GP earlier on to discuss a simple PSA blood test that can check for signs of prostate cancer. Then if there are any issues, they can get it treated it at an earlier stage. 'I've told my story to help raise awareness about the most common cancer in men and get more thinking about their risk and what they can do, but it shouldn't all be men's responsibility. 'I've faced many challenges in my life, and going public with my prostate cancer diagnosis was certainly one of them. 'I've been incredibly lucky to have so much support from my family, friends and the general public. The kindness has lifted me up and given me a sense of purpose, and I'm committed to taking that forward and using my platform to raise awareness of the most common cancer in men and help more men at risk to come forward and get tested.' The Scottish cyclist has launched his own charity cycling challenge, Tour de 4, with the aim of changing perceptions around stage four cancer. The challenge will take place on September 7 in Glasgow with a final registration phase open for riders to sign up. Speaking about Sir Chris, Laura Kerby, chief executive at Prostate Cancer UK, said: 'His bravery and tireless work to raise awareness has already made a huge impact. 'In just a few months after Sir Chris went public with his diagnosis last year, over 286,000 people used our online risk checker to learn more about the disease, find out their own risk and learn what they can choose to do about it. 'His bravery has inspired so many men to take action, and he has undoubtedly saved lives. 'One in eight men will get prostate cancer. The earlier it's found, the easier it is to treat — but there's currently no screening programme in the UK. So if, like Sir Chris, you have a family history of the disease, or if you're black, we strongly encourage you to speak to your GP about testing from the age of 45. 'We don't think it's right that the responsibility is all on men's shoulders, so we're calling on the Health Secretary to overhaul outdated NHS guidelines so that GPs are empowered to actually start conversations with these men at highest risk.' A Government spokesperson said: 'This Government has been clear we would like to see screening in place but the decision must be evidence-led, which is why the UK National Screening Committee is looking at this as a priority – including reviewing the evidence for screening men with a family history of prostate cancer. 'While the review is taking place we are getting on with improving cancer treatment and prevention, as well as funding tens of millions of pounds of research.'
Rhyl Journal
20 hours ago
- Rhyl Journal
Chris Hoy calls for systemic change in testing for prostate cancer
The 49-year old cyclist was diagnosed with stage four prostate cancer in 2023 and was told last year that it has spread to his bones and is terminal. NHS guidance says men over the age of 50 are at highest risk of developing prostate cancer, but Sir Chris wants to help men get screened earlier. He said: 'I was diagnosed with stage four prostate cancer at 47. By this age, my prostate cancer was advanced and could have been progressing from when I was 45 or even younger. 'With prostate cancer, the earlier you find it, the easier it is to treat. We need the system to change to enable more men to get diagnosed earlier, and stop them getting the news I got.' One option is a PSA blood test which checks the level of prostate-specific antigens in the blood, A high reading may be a sign of a prostate condition. NHS guidance says these tests are not routinely used as they are not reliable, but men over 50 can ask GPs for one. Sir Chris's comments came after Prostate Cancer UK urged the UK Government for an overhaul of NHS guidelines to encourage GPs to proactively speak to men at high risk from 45 years old. #ProstateCancer has become the most common cancer in England. However, for a disease that affects 1 in 8 men, there's still no screening programme and outdated NHS guidelines prevent lifesaving conversations with men at highest risk. ➡️ Read more: — Prostate Cancer UK (@ProstateUK) January 28, 2025 According to the charity, around one in eight men in the UK will get prostate cancer, which occurs when cells in the prostate start to grow in an uncontrolled way and, if not detected early, risks spreading. Sir Chris added: 'I believe men at highest risk, for example men with a family history like me or black men, should be contacted by their GP earlier on to discuss a simple PSA blood test that can check for signs of prostate cancer. Then if there are any issues, they can get it treated it at an earlier stage. 'I've told my story to help raise awareness about the most common cancer in men and get more thinking about their risk and what they can do, but it shouldn't all be men's responsibility. 'I've faced many challenges in my life, and going public with my prostate cancer diagnosis was certainly one of them. 'I've been incredibly lucky to have so much support from my family, friends and the general public. The kindness has lifted me up and given me a sense of purpose, and I'm committed to taking that forward and using my platform to raise awareness of the most common cancer in men and help more men at risk to come forward and get tested.' The Scottish cyclist has launched his own charity cycling challenge, Tour de 4, with the aim of changing perceptions around stage four cancer. The challenge will take place on September 7 in Glasgow with a final registration phase open for riders to sign up. Speaking about Sir Chris, Laura Kerby, chief executive at Prostate Cancer UK, said: 'His bravery and tireless work to raise awareness has already made a huge impact. 'In just a few months after Sir Chris went public with his diagnosis last year, over 286,000 people used our online risk checker to learn more about the disease, find out their own risk and learn what they can choose to do about it. 'His bravery has inspired so many men to take action, and he has undoubtedly saved lives. 'One in eight men will get prostate cancer. The earlier it's found, the easier it is to treat — but there's currently no screening programme in the UK. So if, like Sir Chris, you have a family history of the disease, or if you're black, we strongly encourage you to speak to your GP about testing from the age of 45. 'We don't think it's right that the responsibility is all on men's shoulders, so we're calling on the Health Secretary to overhaul outdated NHS guidelines so that GPs are empowered to actually start conversations with these men at highest risk.' A Government spokesperson said: 'This Government has been clear we would like to see screening in place but the decision must be evidence-led, which is why the UK National Screening Committee is looking at this as a priority – including reviewing the evidence for screening men with a family history of prostate cancer. 'While the review is taking place we are getting on with improving cancer treatment and prevention, as well as funding tens of millions of pounds of research.'
Metro
21 hours ago
- Metro
Your earwax might be able to predict if you have Parkinson's disease
Chemical differences in people' earwax may be a telltale sign of Parkinson's that could revolutionise the fight against the disease, new research suggests. Parkinson's disease, which affects physical movement by damaging the brain, is very hard to diagnose early on. The high cost of brain scans means the only widely viable method is a specialist's evaluation of physical symptoms, which develop only after significant damage to the brain has happened. Since early treatment makes a huge difference in later quality of life, experts are keen to find other ways to detect it. The idea that people with Parkinson's give off different chemicals gained traction after credible evidence emerged that they smell noticeably different. Joy Milne, a retired Scottish nurse in her 70s with a rare condition giving her heightened smell, came forward in 2016 after noticing a distinct change in the smell of her late husband when he began to develop the disease. She was able to guess 100% correctly whether randomly picked items of clothing had belonged to someone with Parkinson's. Since then, early research proved promising for a skin swab test that involves running a cotton bud along the back of the neck. Scientists believe people with Parkinson's have different levels of certain compounds in their sebum, an oily substance produced by glands in the skin. Now another potential method building on this may have been discovered by scientists from Zhejiang University in China. Since earwax is made mostly of sebum, they decided to analyse samples from around 200 people who were known to be living with or without Parkinson's. Data on the chemical make-up of their earwax was into an algorithm that correctly guessed whether an individual had Parkinson's or not 94% of the time. This was based on the levels of four specific types of compounds, which were significant regardless of each person's age and lifestyle. Two of them, ethylbenzene & 4-ethyltoluene, are known to be signs of inflammation in the brain previously linked to Parkinson's. More Trending Another was pentanal, which has been linked to accumulations of protein clumps in patients' brains that are a telltale sign of Parkinson's. The study's authors said 'early diagnosis and treatment are crucial' for treatment. It's hoped their model could lead to a chemical testing device that could be easily distributed to clinics. 'Further enhancements to the diagnostic model could pave the way for a promising new PD diagnostic solution and the clinical use of a bedside PD diagnostic device.' Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page.
